Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 2/20 | 0.43 |
| ▸ | PYGL | P06737 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13139827 | 0.82 | XIAP (0.47) | XIAPPYGLLMNAALDH1A1SCN9A | |
| SCHEMBL14370029 | 0.81 | XIAP (0.42) | XIAPPYGLLMNAALDH1A1SCN9A | |
| SCHEMBL645568 | 0.80 | SCN9A (0.51) | XIAPSCN9A | |
| SCHEMBL645694 | 0.80 | SCN9A (0.51) | XIAPSCN9A | |
| SCHEMBL4556966 | 0.80 | NAAA (0.47) | XIAPPYGLLMNASCN9AOPRL1 | |
| SCHEMBL648535 | 0.80 | XIAP (0.48) | XIAPPYGLALDH1A1RIPK1MEN1 | |
| SCHEMBL14370027 | 0.80 | XIAP (0.42) | XIAPPYGLLMNAALDH1A1POLB | |
| SCHEMBL645717 | 0.79 | LMNA (0.43) | XIAPPYGLLMNAALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL645716 | 0.78 | LMNA (0.42) | XIAPPYGLLMNAALDH1A1POLB | |
| SCHEMBL645689 | 0.77 | RIPK1 (0.44) | XIAPPYGLRIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119631-B2 | Inhibitors of interleukin-1β converting enzyme | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-02-21 | — | — | US | disclosed |